Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy
NCT ID: NCT01319318
Last Updated: 2013-07-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2011-03-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bandage Contact Lens in Post Operative Ptosis Patients
NCT03375879
Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects
NCT04984590
Ocular Biomarkers for Successful Premium Trifocal Intra-ocular Lenses Implantation
NCT05863247
Objective and Subjective Evaluation of Ophthalmic Lenses With Extra Power
NCT05089240
Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software
NCT05848817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pars Plana Vitrectomy
Pars plana vitrectomy performed in study eye on Day 0.
Pars Plana Vitrectomy
Pars plana vitrectomy performed in study eye on Day 0.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pars Plana Vitrectomy
Pars plana vitrectomy performed in study eye on Day 0.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity in the study eye between 20/400 and 20/40
Exclusion Criteria
* Use of topical or systemic steroids within 30 days
* Active eye infection in either eye
* Any eye surgery within 6 months
* Prior pars plana vitrectomy, YAG capsulotomy or uveitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GMA-OZU-10-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.